Exforge er også undersøgt i et aktivt kontrolleret studie med 130 hypertensive patienter med diastolisk blodtryk ≥110 mmHg og < 120 mmHg.
Exforge was also studied in an active-controlled study of 130 hypertensive patients with diastolic blood pressure ≥ 110 mmHg and < 120 mmHg.